|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Breast cancer
A Real-world Efficacy of Nab-
paclitaxel
Monotherapy in Metastatic Breast Cancer
Jung Sun Kim, Koung Jin Suh, Dae-Won Lee, Go-un Woo, Miso Kim, Se Hyun Kim, Han Suk Ryu, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, So Yeon Park, In Ae Park, Jee Hyun Kim, Seock-Ah Im
Cancer Res Treat.
2022;54(2):488-496. Published online August 13, 2021 DOI:
https://doi.org/10.4143/crt.2021.394
Web of Science 3
Crossref 4
Sarcoma
Real-World Clinical Outcomes and Prognostic Factors for Patients with Advanced Angiosarcoma who Received Systemic Treatment
Changhee Park, Miso Kim, Yoonjin Kwak, Kyung Chul Moon, Se Hyun Kim, Bhumsuk Keam, Yu Jung Kim, Tae Min Kim, Dong-Wan Kim
Cancer Res Treat.
2021;53(4):1195-1203. Published online February 1, 2021 DOI:
https://doi.org/10.4143/crt.2020.1337
Web of Science 4
Crossref 4
Clinical Outcomes of Second-Line Chemotherapy after Progression on
Nab
-
Paclitaxel
Plus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
Kyoungmin Lee, Kyunghye Bang, Changhoon Yoo, Inhwan Hwang, Jae Ho Jeong, Heung-Moon Chang, Dongwook Oh, Tae Jun Song, Do Hyun Park, Sang Soo Lee, Sung Koo Lee, Myung-Hwan Kim, Jin-hong Park, Kyu-pyo Kim, Baek-Yeol Ryoo
Cancer Res Treat.
2020;52(1):254-262. Published online July 9, 2019 DOI:
https://doi.org/10.4143/crt.2019.190
Web of Science 10
Crossref 12
Prediction of Acquired Taxane Resistance Using a Personalized Pathway-Based Machine Learning Method
Young Rae Kim, Dongha Kim, Sung Young Kim
Cancer Res Treat.
2019;51(2):672-684. Published online August 10, 2018 DOI:
https://doi.org/10.4143/crt.2018.137
Web of Science 6
Crossref 6
An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated
Paclitaxel
Compared to Conventional Cremophor EL-Based
Paclitaxel
for Recurrent or Metastatic HER2-Negative Breast Cancer
In Hae Park, Joo Hyuk Sohn, Sung Bae Kim, Keun Seok Lee, Joo Seop Chung, Soo Hyeon Lee, Tae You Kim, Kyung Hae Jung, Eun Kyung Cho, Yang Soo Kim, Hong Suk Song, Jae Hong Seo, Hun Mo Ryoo, Sun Ah Lee, So Young Yoon, Chul Soo Kim, Yong Tai Kim, Si Young Kim, Mi Ryung Jin, Jungsil Ro
Cancer Res Treat.
2017;49(3):569-577. Published online September 12, 2016 DOI:
https://doi.org/10.4143/crt.2016.289
Web of Science 66
Crossref 62
A Phase II Study of Weekly
Paclitaxel
Plus Gemcitabine as a Second-Line Therapy in Patients with Metastatic or Recurrent Small Cell Lung Cancer
Tak Yun, Heung Tae Kim, Ji-Youn Han, Sung Jin Yoon, Hyae Young Kim, Byung-Ho Nam, Jin Soo Lee
Cancer Res Treat.
2016;48(2):465-472. Published online May 26, 2015 DOI:
https://doi.org/10.4143/crt.2015.061
Web of Science 11
Crossref 12
Blockade of Autophagy Aggravates Endoplasmic Reticulum Stress and Improves
Paclitaxel
Cytotoxicity in Human Cervical Cancer Cells
Li Xu, Jing-Hua Liu, Jing Zhang, Na Zhang, Zan-Hong Wang
Cancer Res Treat.
2015;47(2):313-321. Published online September 11, 2014 DOI:
https://doi.org/10.4143/crt.2013.222
Web of Science 38
Crossref 33
A Phase I Study of Oral
Paclitaxel
with a Novel P-Glycoprotein Inhibitor, HM30181A, in Patients with Advanced Solid Cancer
Hyun Jung Lee, Dae-Seog Heo, Joo-Youn Cho, Sae-Won Han, Hye-Jung Chang, Hyeon-Gyu Yi, Tae-Eun Kim, Se-Hoon Lee, Do-Youn Oh, Seock-Ah Im, In-Jin Jang, Yung-Jue Bang
Cancer Res Treat.
2014;46(3):234-242. Published online July 15, 2014 DOI:
https://doi.org/10.4143/crt.2014.46.3.234
Web of Science 16
Crossref 15
Synergistic Effect of COX-2 Inhibitor on
Paclitaxel
-Induced Apoptosis in the Human Ovarian Cancer Cell Line OVCAR-3
Hee Jung Kim, Ga Won Yim, Eun Ji Nam, Young Tae Kim
Cancer Res Treat.
2014;46(1):81-92. Published online January 15, 2014 DOI:
https://doi.org/10.4143/crt.2014.46.1.81
Web of Science 25
Crossref 20
Phase II Study of Consolidation Chemotherapy after Adjuvant or Primary Concurrent Chemoradiation Using
Paclitaxel
and Carboplatin to Treat High-Risk Early-Stage or Locally Advanced Cervical Cancer
Hee Seung Kim, Mi-Kyung Kim, Hak Jae Kim, Seung-Su Han, Jae Weon Kim
Cancer Res Treat.
2012;44(2):97-103. Published online June 30, 2012 DOI:
https://doi.org/10.4143/crt.2012.44.2.97
Crossref 21
Docetaxel versus
Paclitaxel
Combined with 5-FU and Leucovorin in Advanced Gastric Cancer: Combined Analysis of Two Phase II Trials
Hong Jae Chon, Sun Young Rha, Chong Kun Im, Chan Kim, Min Hee Hong, Hye Ryun Kim, Jung Ryun An, Sung Hoon Noh, Hyun Cheol Chung, Hei-Cheul Jeung
Cancer Res Treat.
2009;41(4):196-204. Published online December 31, 2009 DOI:
https://doi.org/10.4143/crt.2009.41.4.196
Crossref 22
A Phase II Trial of
Paclitaxel
, 5-fluorouracil (5-FU) and Cisplatin in Patients with Metastatic or Recurrent Gastric Cancer
Gun Hi Kang, Gwang Sil Kim, Hyo Rak Lee, Young Jin Yuh, Sung Rok Kim
Cancer Res Treat.
2008;40(3):106-110. Published online September 30, 2008 DOI:
https://doi.org/10.4143/crt.2008.40.3.106
Crossref 7
A Phase II Study of
Paclitaxel
and Cisplatin as Salvage Therapy for Patients with Advanced or Metastatic Gastric Cancer
Bong-Gun Seo, Sung Yong Oh, Dong Mee Lee, Hyun Seung Yoo, Suee Lee, Seong-Geun Kim, Sung-Hyun Kim, Hyuk-Chan Kwon, Hyo-Jin Kim
Cancer Res Treat.
2007;39(1):6-9. Published online March 31, 2007 DOI:
https://doi.org/10.4143/crt.2007.39.1.6
Crossref 2
A Multi-Center, Phase II Clinical Trial of Padexol™ (
Paclitaxel
) and Cisplatin for Patients Suffering with Advanced Gastric Cancer
Min Kyoung Kim, Kyung Hee Lee, Myung Soo Hyun, Young Rok Do, Hong Suk Song, Won Sik Lee, Keon Uk Park, Jin Ho Baek, Jong Gwang Kim
Cancer Res Treat.
2005;37(6):349-353. Published online December 31, 2005 DOI:
https://doi.org/10.4143/crt.2005.37.6.349
Crossref 8
Proteome Analysis of Differential Protein Expression in Cervical Cancer Cells after
Paclitaxel
Treatment
Eun-Kyoung Yim, Jun-Sang Bae, Seung-Bak Lee, Keun-Ho Lee, Chan-Joo Kim, Sung-Eun Namkoong, Soo-Jong Um, Jong-Sup Park
Cancer Res Treat.
2004;36(6):395-399. Published online December 31, 2004 DOI:
https://doi.org/10.4143/crt.2004.36.6.395
Crossref 6
A Phase II Study of Weekly
Paclitaxel
, Cisplatin and Concurrent Radiation Therapy for Locally-Advanced Unresectable Non-Small Cell Lung Cancer: Early Closure due to Lack of Efficacy
Se Hoon Park, Mi Kyung Kim, Sun Young Kyung, Young-Hee Lim, Chang Hyeok An, Jeong Woong Park, Seong Hwan Jeong, Jae Woong Lee, Kyu Chan Lee, Eun Kyung Cho, Soo Mee Bang, Dong Bok Shin, Jae Hoon Lee
Cancer Res Treat.
2004;36(5):293-297. Published online October 31, 2004 DOI:
https://doi.org/10.4143/crt.2004.36.5.293
Paclitaxel
and Cisplatin Combination Chemotherapy in Pretreated Breast Cancer
Joo Hyuk Sohn, Yong Tai Kim, Sun Young Rha, Nae Choon Yoo, Jae Kyung Roh, Byung Soo Kim, Chang Ok Suh, Gwi Eon Kim, Woo Ick Jang, Hyun Cheol Chung
Cancer Res Treat.
2003;35(3):267-273. Published online June 30, 2003 DOI:
https://doi.org/10.4143/crt.2003.35.3.267
Crossref 5
A Phase II Study of
Paclitaxel
and Cisplatin Combination Chemotherapy in Advanced Non-small-cell Lung Cancer
Jung Ae Lee, Keun Seok Lee, Jin Seok Ahn, Jae Ho Byun, Hun Ho Song, Dae Young Zang, Young Iee Park, Young Suk Park, Eun Kyung Mo, Dong Kyu Kim, Myung Goo Lee, In Gyu Hyun, Ki Suck Jung, Soo Mee Bang, Gye Young Park, Jeong Woong Park, Eun Kyung Cho, Seong Hwan Jeong, Dong Bok Shin, Jae Hoon Lee
Cancer Res Treat.
2003;35(3):239-244. Published online June 30, 2003 DOI:
https://doi.org/10.4143/crt.2003.35.3.239
Crossref 1
A Multi-Center, Phase II Clinical Trial of Genexol(R) (
Paclitaxel
) and Cisplatin for Patients with Non-Small Cell Lung Cancer
Se Hoon Lee, Keunchil Park, Cheolwon Suh, Hoon Kyo Kim, Jun Suk Kim, Young Hyuck Im, Sang We Kim, Dae Seog Heo, Yung Jue Bang, Noe Kyeong Kim
Cancer Res Treat.
2003;35(1):30-34. Published online February 28, 2003 DOI:
https://doi.org/10.4143/crt.2003.35.1.30
Crossref 4
Antitumor Activity of Oxaliplatin, 5-FU and
Paclitaxel
Given Alone or in Combination with ZD1839 in Human Gastric Carcinoma Cells in vitro
Ji Hyun Jang, Sang Hak Lee, Jin Hyoung Kang, Hee Sik Sun, Kazuto Nishio, Nagahiro Saijo, Hyo Jeong Kuh
Cancer Res Treat.
2002;34(5):372-381. Published online October 31, 2002 DOI:
https://doi.org/10.4143/crt.2002.34.5.372
Crossref 2
Efficacy of Combination Chemotherapy with
Paclitaxel
and Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer
Eun Jung Rhee, Hyun Sik Jeong, Seung Sei Lee
Cancer Res Treat.
2002;34(1):28-33. Published online February 28, 2002 DOI:
https://doi.org/10.4143/crt.2002.34.1.28
Crossref 3
Efficacy of Low-dose
Paclitaxel
and Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer
Byung Su Kim, Do Youn Oh, Yo Han Joh, Do Yeun Kim, Jee Hyun Kim, Se Hoon Lee, Dae Ho Lee, Tae You Kim, Dae Seog Heo, Yung Jue Bang, Noe Kyeong Kim
Cancer Res Treat.
2001;33(6):469-473. Published online December 31, 2001 DOI:
https://doi.org/10.4143/crt.2001.33.6.469
Crossref 2
Phase I Clinical Trial of
Paclitaxel
Plus Ifosfamide for the Patients with Refractory Ovarian Cancer
Ho Sawk Saw, Jae Kwan Lee
J Korean Cancer Assoc.
2000;32(5):895-903.
Phase II Multicenter Trial of
Paclitaxel
for Metastatic Breast Cancer
Jae Ho Byun, Sung Soo Yoon, Chan Hyung Park, Sung Rok Kim, Si Young Kim, Hyo Jin Kim, Soo Mee Bang, Heung Moon Chang, Dae Seog Heo, Yung Jue Bang, Noe Kyeong Kim
J Korean Cancer Assoc.
2000;32(3):545-552.
Effect of Paclitaxol, Cisplatin, and 5-Flurouracil Chemotherapy in Advanced Stomach Cancer
Yeul Hong Kim, Sang Won Shin, Byung Soo Kim, Jin Ho Kim, Jong Kuk Kim, Young Jae Mok, Jong Suk Kim, Chi Wook Song, Ho Sang Ryu, Jun Suk Kim, Jin Hai Hyun
J Korean Cancer Assoc.
1997;29(4):648-655.
A Single-Arm Phase II Study of Nab-
Paclitaxel
Plus Gemcitabine and Cisplatin for Locally Advanced or Metastatic Biliary Tract Cancer
Ting Liu, Qing Li, Zhen Lin, Chunhua Liu, Wei Pu, Shasha Zeng, Jun Lai, Xuebin Cai, Lisha Zhang, Shuyang Wang, Miao Chen, Wei Cao, Hongfeng Gou, Qing Zhu
Received June 6, 2023 Accepted October 10, 2023 Published online October 12, 2023
DOI:
https://doi.org/10.4143/crt.2023.726
[Epub ahead of print]
1
Journal Impact Factor 4.6